Cargando…

Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer

SIMPLE SUMMARY: Internationally, in women, breast cancer (BC) is the most common cancer type and is the leading cause of cancer-related death. There are two main histological classifications of BC, carcinoma in situ and carcinoma invasive. BC is further histologically subclassified as ductal carcino...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinnel, Briana, Singh, Santosh Kumar, Oprea-Ilies, Gabriela, Singh, Rajesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954028/ https://www.ncbi.nlm.nih.gov/pubmed/36831661 http://dx.doi.org/10.3390/cancers15041320

Ejemplares similares

Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
por: McFadden, Melayshia, et al.
Publicado: (2021)

The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer
por: McFadden, Melayshia, et al.
Publicado: (2023)

The interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparity
por: Haynes, Talaijha, et al.
Publicado: (2022)

Drug delivery approaches for breast cancer
por: Singh, Santosh Kumar, et al.
Publicado: (2017)

CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling
por: Mir, Hina, et al.
Publicado: (2021)

Silencing of E2F3 suppresses tumor growth of Her2(+) breast cancer cells by restricting mitosis
por: Lee, Miyoung, et al.
Publicado: (2015)

The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer
por: Harbuzariu, Adriana, et al.
Publicado: (2018)

Understanding the Mechanism of Bacterial Biofilms Resistance to Antimicrobial Agents
por: Singh, Shriti, et al.
Publicado: (2017)

Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition
por: Singh, Sunanda, et al.
Publicado: (2023)

Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance
por: Wu, Jiajia, et al.
Publicado: (2022)

Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems
por: Lainetti, Patrícia de Faria, et al.
Publicado: (2020)

Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms
por: Famta, Paras, et al.
Publicado: (2021)

Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers
por: Singh, Navneet, et al.
Publicado: (2022)

Cytokines and Chemokines in Cancer Cachexia and Its Long-Term Impact on COVID-19
por: Singh, Santosh Kumar, et al.
Publicado: (2022)

Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics
por: Tiwari, Harshita, et al.
Publicado: (2023)

NILCO biomarkers in breast cancer from Chinese patients
por: Colbert, Laronna S, et al.
Publicado: (2014)

Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
por: Gote, Vrinda, et al.
Publicado: (2021)

Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer
por: Singh, Santosh Kumar, et al.
Publicado: (2020)

Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
por: Lim, Zuan-Fu, et al.
Publicado: (2019)

Cancer Targeting and Diagnosis: Recent Trends with Carbon Nanotubes
por: Singh, Ragini, et al.
Publicado: (2022)

Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance
por: Schrank, Zachary, et al.
Publicado: (2018)

Role of Midkine in Cancer Drug Resistance: Regulators of Its Expression and Its Molecular Targeting
por: Saikia, Minakshi, et al.
Publicado: (2023)

Mechanisms of resistance to EGFR-targeted drugs: lung cancer
por: Morgillo, Floriana, et al.
Publicado: (2016)

Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival
por: Oprea-Ilies, Gabriela, et al.
Publicado: (2012)

Drug resistance in targeted cancer therapies with RAF inhibitors
por: Degirmenci, Ufuk, et al.
Publicado: (2021)

RET in breast cancer: pathogenic implications and mechanisms of drug resistance
por: Lo Nigro, Cristiana, et al.
Publicado: (2019)

Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions
por: Chen, Yu‐Fei, et al.
Publicado: (2022)

Targeting stem cells in the realm of drug-resistant breast cancer
por: Dey, Pranay, et al.
Publicado: (2019)

Emerging targets in cancer drug resistance
por: Kumar, Shashank, et al.
Publicado: (2019)

Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
por: Lee, Shannon, et al.
Publicado: (2020)

Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
por: Alatise, Kharimat Lora, et al.
Publicado: (2022)

Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
por: Huang, Mian, et al.
Publicado: (2023)

Clinical Implication of Metformin in Relation to Diabetes Mellitus and Ovarian Cancer
por: Singh, Santosh Kumar, et al.
Publicado: (2021)

Drug repurposing for breast cancer therapy: Old weapon for new battle
por: Aggarwal, Sadhna, et al.
Publicado: (2021)

Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia
por: Singh, Santosh Kumar, et al.
Publicado: (2021)

CAR T cell therapy: newer approaches to counter resistance and cost
por: Yadav, Rajesh Kumar, et al.
Publicado: (2020)

Noncoding RNAs in cancer therapy resistance and targeted drug development
por: Wang, Wen-Tao, et al.
Publicado: (2019)

Drug and hormonal resistance in breast cancer: cellular and molecular mechanisms
por: Dowsett, M
Publicado: (1996)

Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery
por: Ding, Kun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_remur75r6n4qi5urtqi29rf5f0